Tang Capital Management 13F annual report

Publish date: 2024-05-03

Tang Capital Management is an investment fund managing more than $497 million ran by Kevin Tang. There are currently 29 companies in Mr. Tang’s portfolio. The largest investments include AnaptysBio Inc and Heron Therapeutics Inc, together worth $162 million.

$497 million Assets Under Management (AUM)

As of 7th February 2022, Tang Capital Management’s top holding is 2,628,678 shares of AnaptysBio Inc currently worth over $91.3 million and making up 18.4% of the portfolio value. Relative to the number of outstanding shares of AnaptysBio Inc, Tang Capital Management owns less than approximately 0.1% of the company. In addition, the fund holds 7,782,928 shares of Heron Therapeutics Inc worth $71.1 million, whose value fell approximately 0.1% in the past six months. The third-largest holding is Rocket Pharmaceuticals Inc worth $55.3 million and the next is La Jolla Pharmaceutical Co worth $44.7 million, with 9,607,934 shares owned.

Currently, Tang Capital Management's portfolio is worth at least $497 million. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Tang Capital Management

The Tang Capital Management office and employees reside in San Diego, California. According to the last 13-F report filed with the SEC, Kevin Tang serves as the Manager at Tang Capital Management.

ncG1vNJzZmivkaG5rrXNnmWcp51ks7a6w2hqa3Bfqa6vs4ycmKmhpJa5brnAp5ignZ2au7V5y6Wa